Indian Journal of Pharmaceutical Sciences
Users online: 202
Scientific Publication of the Indian Pharmaceutical Association
Home Email this page Print this page Bookmark this page Decrease font size Default font size Increase font size
The Journal Search Current Issue Archives Instructions Online submission Login  
Year : 2001  |  Volume : 63  |  Issue : 3  |  Page : 239-243

Study Of Antiparkinson’s Activity Of Plain And Niosomal Pentoxifylline


,

Correspondence Address:
Aarti Jagtap


Login to access the Email id


Get Permissions

The objective of the study was to investigate the antiparkinson's activity of plain and niosomal pentoxifylline. Pentoxifylline was entrapped in niosomes by lipid layer hydration method using Span 60, cholesterol and dicetyl phosphate (10 mg : 10 mg : 2.5 mg). The antiparkinson's activity was investigated on cataleptic score in haloperidol-induced catalepsy model, and locomotor activity in reserpine antagonism and adenosine antagonism at different doses of plain pentoxifylline (40,80 mg/kg) and niosomal pentoxifylline (5,10,15 mg/kg). Plain pentoxifylline (80 mg/kg) and niosomal pentoxifylline (5,10,15 mg/kg) gave significant improvement in haloperidol-induced catalepsy. Plain pentoxifylline (80 mg/kg) and niosornal pentoxifylline (10, 15 mg/kg) showed significant increase in locomotor avtivity of reserpinetreated mice and adenosine-treated rats. Results suggest that pentoxifyl!ine may prove to be an effective drug in Parkinson's treatment as an adjuvant.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed201    
    Printed14    
    Emailed0    
    PDF Downloaded43    
    Comments [Add]    

Recommend this journal